Views & Analysis Healthcare in 2030: what role for pharma? Prevention and self-management increasingly important in healthcare systems of the future.
Views & Analysis Highs and lows in regenerative medicine How developments in gene editing and screening technology are advancing regenerative medicine.
Views & Analysis The future of brand management What pharma brand management must entail to ensure pharma retains its position and maintains sales.
Views & Analysis Demonstrating value – the future for market access With the US joining other countries around the world in demanding definitions and measurements of the value of treatments, the pharma industry faces the challenge of understanding the requireme
Views & Analysis Utilise medtech for optimum care management Medtech companies can provide the tools to empower patients and HCPs.
Views & Analysis Healthcare’s hype cycle: which technologies will stay the co... Where should pharma invest to remain at the forefront of healthcare?
News Court sides with EU on decision to revoke Ocaliva's license Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
